3D Printing Cardiac Components for Pediatric Patients: Interview with Prof. Michael Davis
Congenital heart disease is the most common birth defect globally, affecting almost nine in every 1,000 babies. Tissue engineering, which involves combining regenerative cells, proteins, or drugs with biomaterials, is a promising strategy to treat congenital heart diseases. A particularly exciting development is the use of 3D printers to fabricate custom cardiac components to replace diseased tissues, such as heart valves, or create cardiac patches that can provide therapeutic benefit to cardiac tissues. Click here to read the article.